Embody vs Henry Meds

Neither Embody nor Henry Meds has an FDA warning letter on record. On compounded tirzepatide injection, Embody costs $2,640 less a year at standing rates: $129 a month against $349 a month at Henry Meds. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / Henry Meds

Featured pick (affiliate partner)

Embody logo

Embody

9.3/10

Henry Meds logo

Henry Meds

5.6/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$249/moCompounded oral semaglutide
States
All 50 states and DC
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Henry Meds pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Henry Meds 5.6). How we are paid

What the record shows

  1. 01

    Neither Embody nor Henry Meds has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. Henry Meds names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Embody costs $2,640 less a year at standing rates: $129 a month against $349 a month at Henry Meds. It is one of two products the two sell at comparable terms.

  4. 04

    Only Embody lists a price for compounded oral tirzepatide. Only Henry Meds lists a price for compounded oral semaglutide.

  5. 05

    Embody lists all 50 states and DC. Henry Meds publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

Henry Meds

Compounded semaglutide injection

$79/moLower

$948 a year

$297/mo

$3,564 a year

Compounded tirzepatide injection

$129/moLower

$1,548 a year

$349/mo

$4,188 a year

Compounded oral semaglutide
Not sold or not priced

$249/mo

$2,988 a year

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
None on monthly plans; longer plans are offered for some treatments
Refunds
No refunds once paid; a partial refund only after a medical disqualification
Subscription fees generally non-refundable; medication is final sale once shipped
Early-exit fee
None stated
Yes

Read off each seller’s own pages. Embody: October 30, 2026. Henry Meds: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
Featured pick (affiliate partner)
  • $2,616 a year less on compounded semaglutide injection
  • $2,640 a year less on compounded tirzepatide injection
  • Sells compounded oral tirzepatide, which Henry Meds does not price
  • Names its compounding pharmacy

The case for Henry Meds

5.6/10
  • Sells compounded oral semaglutide, which Embody does not price
  • Names no compounding pharmacy
  • Publishes no state list

Scores

Embody 9.3 · Henry Meds 5.6 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

9.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs Henry Meds: questions

Neither Embody nor Henry Meds has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. Henry Meds names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Embody, by $2,616 a year at standing rates. Embody: $79 a month, about $948 a year. Henry Meds: $297 a month, about $3,564 a year.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. Henry Meds states you can cancel at any time; refunds: subscription fees generally non-refundable; medication is final sale once shipped.
Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Henry Meds pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, Henry Meds 5.6).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register